Evaluation of Cardiac Findings Before Laboratory-Based Polysomnography

Öz

Aim: This study aimed to determine the demographic characteristics of the patients who applied to the Cardiology Out-patient Clinic before laboratory-based polysomnography was performed. Material and Method: 123 adult patients undergoing laboratory-based polysomnography were included in this retrospective study. The demographic features of the patients were recorded. Routine laboratory tests, electrocardiography (ECG), transthoracic echocardiography (TTE), 24-hour ambulatory blood pressure monitoring, cardiovascular stress test, and laboratory-based polysomnography were performed in the same hospital. The apnea-hypopnea index (AHI) was used to diagnose obstructive sleep apnea syndrome (OSAS). Results: In this study, we found the following patient findings. The mean age of the patients was 49±1.61 years. The majority of the patients were in the middle age group. Forty-two (34.10%) patients were female and 81 (65.90%) were male. Normal AHI value was detected in 5 (4.2%) patients. Mild OSAS was detected in 30 (24.2%) of the patients, moderate OSAS in 24 (18.9%), and severe OSAS in 64 (51.6%). Continuous positive airway pressure (CPAP) device report was given to 67 (54.7%) of the patients. The most accompanying comorbidity of the patients was hypertension (HT). There was a weak positive correlation between AHI and HT; r=0.280, N=95, and the relationship was statistically significant (p=0.006). Nine (7.30%) of the patients were newly diagnosed with hypertension. Invasive coronary angiography was recommended for two (1.6%) patients with positive test results, and coronary computed tomographic angiography was recommended for four (3.2%) patients. Myocardial perfusion scintigraphy was recommended to nine (7.3%) patients who could not perform cardiovascular stress tests. Conclusion: Cardiac evaluation should be performed before laboratory-based polysomnography is performed. Electrocardiography and TTE recording should be performed on the patients, and 24-hour ABPM should be inserted. Additional tests should be performed to investigate ischemia in patients with myocardial ischemia findings.

Anahtar Kelimeler

• obstructive sleep apnea syndrome
• polysomnography
• cardiology

Kaynakça

1. 1. Dunai A, Mucsi I, Juhasz J, et al. Obstructive sleep apnea and cardiovascular disease. Orv Hetil. 2006;147(48):2303-2311.
2. 2. Levy P, Kohler M, McNicholas W, et al. Obstructive sleep apnoea syndrome. Nat Rev Dis Primers. 2015;1:15015.
3. 3. Maspero C, Giannini L, Galbiati G, et al. Obstructive sleep apnea syndrome: a literature review. Minerva Stomatol. 2015;64(2):97-109.
4. 4. Voulgaris A, Archontogeorgis K, Pataka A, et al. Burden of Comorbidities in Patients with OSAS and COPD-OSAS Overlap Syndrome. Medicina (Kaunas). 2021;57(11):1201.
5. 5. Nieto FJ, Young TB, Lind BK, et al. Association of sleepdisordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000;283(14):1829-1836.
6. 6. Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med. 2000;160(15):2289-2295.
7. 7. Botros N, Concato J, Mohsenin V, et al. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med. 2009;122(12):1122-1127.
8. 8. Shaw JE, Punjabi NM, Wilding JP, et al. International Diabetes Federation Taskforce on Epidemiology and Prevention. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract. 2008;81(1):2-12.

9. 9. Keckeis M, Lattova Z, Maurovich-Horvat E, et al. Impaired glucose tolerance in sleep disorders. PLoS ONE. 2010;5(3):e9444.
10. 10. Punjabi NM, Shahar E, Redline S, et al. Sleep Heart Health Study Investigators. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol. 2004;160(6):521-530.
11. 11. Punjabi NM, Beamer BA. Alterations in Glucose Disposal in Sleep-disordered Breathing. Am J Respir Crit Care Med. 2009;179(3):235-240.
12. 12. Aronsohn RS, Whitmore H, Van Cauter E, et al. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med. 2010;181(5):507-513.
13. 13. Otake K, Sasanabe R, Hasegawa R, et al. Glucose intolerance in Japanese patients with obstructive sleep apnea. Intern Med. 2009;48(21):1863-1868.
14. 14. Mahmood K, Akhter N, Eldeirawi K, et al. Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample. J Clin Sleep Med. 2009;5(3):215-221.
15. 15. Meslier N, Gagnadoux F, Giraud P, et al. Impaired glucoseinsulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J. 2003;22(1):156-160.
16. 16. Levinson PD, McGarvey ST, Carlisle CC, et al. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest. 1993;103(5):1336-1342.
17. 17. Mehra R, Benjamin EJ, Shahar E, et al. Sleep Heart Health Study. Association of nocturnal arrhythmias with sleepdisordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med. 2006;173(8):910-916.
18. 18. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998;97(21):2154-2159.
19. 19. Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999;160(4):1101-1106.
20. 20. Harrison E, Roth RH, Lobo JM, et al. Sleep time and efficiency in patients undergoing laboratory-based polysomnography. J Clin Sleep Med. 2021;17(8):1591-1598.
21. 21. Adir Y, Humbert M, Chaouat A. Sleep-related breathing disorders and pulmonary hypertension. Eur Respir J. 2021;57(1):2002258.
22. 22. Wuest W, May MS, Wiesmueller M, et al. Effect of long term CPAP therapy on cardiac parameters assessed with cardiac MRI. Int J Cardiovasc Imaging. 2021;37(2):613-621.